Survival of patients with pseudomyxoma peritonei treated by serial debulking

Colorectal Disease

Volumn 12, Issue 9, 2010, Pages 868-872

  Jarvinen P ^a   Jarvinen H J ^a   Lepisto A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Pseudomyxoma peritonei; Serial debulking; Survival

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; THIOTEPA;

ABDOMINAL SURGERY; ADULT; AGED; ANASTOMOSIS LEAKAGE; APPENDECTOMY; ARTICLE; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOLECYSTECTOMY; CLINICAL ARTICLE; COLON RESECTION; COLOSTOMY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FEMUR SHAFT FRACTURE; HEMOPERITONEUM; HUMAN; HYPERTHERMIC THERAPY; HYSTERECTOMY; ILEOSTOMY; LUNG EMBOLISM; MALE; MORTALITY; OMENTUM; ORCHIECTOMY; OSTEOSYNTHESIS; OUTCOME ASSESSMENT; OVARIECTOMY; PERITONECTOMY; PERITONEUM PSEUDOMYXOMA; PEROPERATIVE CARE; PLEURECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SMALL INTESTINE RESECTION; SPLENECTOMY; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL WOUND; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; THORACOSCOPY; THORACOTOMY; TREATMENT INDICATION; VENA CAVA FILTER;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77955748516     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.01947.x     Document Type: Article

References (20)

1. Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 2004, 25:411-4.
2. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008, 34:196-201.
3. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D. Pseudomyxoma peritonei syndrome. Adv Surg 1996, 30:233-80.
4. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to " pseudomyxoma peritonei" Am J Surg Pathol 1995, 19:1390-408.
5. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001, 92:85-91.
6. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999, 6:727-31.
7. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005, 241:300-8.
8. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998, 85:1332-9.
9. Esquivel J, Sugarbaker PH. Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg 2000, 87:1414-8.
10. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994, 219:112-9.
11. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res 2007, 134:247-64.
12. Sugarbaker PH. Carcinomatosis from gastrointestinal cancer. Ann Med 2004, 36:9-22.
13. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003, 12:585-603.
14. Mann WJ, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer 1990, 66:1636-40.
15. Elias D, Honore C, Ciuchendea R, Billard V, Raynard B, Lo Dico R. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008, 95:1164-71.
16. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007, 245:104-9.
17. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001, 27:239-43.
18. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999, 6:790-6.
19. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006, 13:635-44.
20. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006, 7:69-76.